Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[How to prevent Hansen's disease].

A P de Mesquita

    Hansenologia Internationalis
    |January 1, 1985
    PubMed
    Summary

    Active patient and community involvement are key for Hanseniasis (leprosy) prevention. Increased access to sulfone medication and dedicated research funding are crucial for combating the disease effectively.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Cutaneous amyloidosis: classification].

    Medicina cutanea ibero-latino-americana·1984
    Same author

    [Health education in Hansen's disease].

    Hansenologia internationalis·1983
    Same author

    [Hansen's disease: its image, education, integration and physician-patient relationship].

    Hansenologia internationalis·1979
    Same author

    [Dr. Ernani Agrícola (1883-1978)].

    Boletim da Divisao Nacional de Dermatologia Sanitaria·1978
    Same author

    [Framboesiform leishmaniasis].

    Anais brasileiros de dermatologia·1967
    Same author

    [Epidermodysplasia verriciformis (Lewandosvsky e Lutz) (E.V.)].

    Anais brasileiros de dermatologia·1966

    Area of Science:

    • Public Health
    • Infectious Disease Epidemiology
    • Medical Research

    Context:

    • Hanseniasis, commonly known as leprosy, remains a significant public health concern requiring proactive management strategies.
    • Effective control necessitates a multi-faceted approach involving patient engagement and accessible treatment options.

    Purpose:

    • To outline optimal prophylactic measures for Hanseniasis.
    • To emphasize the importance of patient and community participation in disease surveillance and early detection.
    • To advocate for improved drug accessibility and dedicated research infrastructure.

    Summary:

    • Prophylaxis of Hanseniasis involves the active participation of patients and their contacts in disease recognition and reporting.
    • Unrestricted sale of sulfone medication is recommended to enhance patient access to treatment.
    • The establishment of a dedicated Institute of Scientific Research for Hanseniasis is proposed.
    • Increased funding through governmental, private, and institutional contributions is essential.

    Impact:

    • Enhanced community awareness and early case detection can significantly reduce Hanseniasis transmission.
    • Improved access to sulfone therapy will lead to better treatment outcomes and reduced disease burden.
    • A focused research institute will accelerate the development of novel diagnostic and therapeutic strategies for Hanseniasis.
    • Sustained financial support is critical for the long-term success of Hanseniasis control programs.

    Related Experiment Videos